Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
National Clinical Research Center for Geriatric Disorders, Central South University, Changsha, China.
CNS Neurosci Ther. 2022 Dec;28(12):2206-2217. doi: 10.1111/cns.13963. Epub 2022 Sep 11.
We mainly evaluate retinal alterations in Alzheimer's disease (AD) patients, investigate the associations between retinal changes with AD biomarkers, and explore an optimal machine learning (ML) model for AD diagnosis based on retinal thickness.
A total of 159 AD patients and 299 healthy controls were enrolled. The retinal parameters of each participant were measured using optical coherence tomography (OCT). Additionally, cognitive impairment severity, brain atrophy, and cerebrospinal fluid (CSF) biomarkers were measured in AD patients.
AD patients demonstrated a significant decrease in the average, superior, and inferior quadrant peripapillary retinal nerve fiber layer, macular retinal nerve fiber layer, ganglion cell layer (GCL), inner plexiform layer (IPL) thicknesses, as well as total macular volume (TMV) (all p < 0.05). Moreover, TMV was positively associated with Mini-Mental State Examination and Montreal Cognitive Assessment scores, IPL thickness was correlated negatively with the medial temporal lobe atrophy score, and the GCL thickness was positively correlated with CSF Aβ /Aβ and negatively associated with p-tau level. Based on the significantly decreased OCT variables between both groups, the XGBoost algorithm exhibited the best diagnostic performance for AD, whose four references, including accuracy, area under the curve, f1 score, and recall, ranged from 0.69 to 0.74. Moreover, the macular retinal thickness exhibited an absolute superiority for AD diagnosis compared with other enrolled variables in all ML models.
We identified the retinal alterations in AD patients and found that macular thickness and volume were associated with AD severity and biomarkers. Furthermore, we confirmed that OCT combined with ML could serve as a potential diagnostic tool for AD.
我们主要评估阿尔茨海默病(AD)患者的视网膜改变,研究视网膜变化与 AD 生物标志物之间的关系,并探索基于视网膜厚度的 AD 诊断的最佳机器学习(ML)模型。
共纳入 159 例 AD 患者和 299 例健康对照者。使用光学相干断层扫描(OCT)测量每位参与者的视网膜参数。此外,还测量了 AD 患者的认知障碍严重程度、脑萎缩和脑脊液(CSF)生物标志物。
AD 患者的平均、上象限和下象限视盘周围神经纤维层、黄斑神经纤维层、节细胞层(GCL)、内丛状层(IPL)厚度以及总黄斑体积(TMV)均显著降低(均 P < 0.05)。此外,TMV 与简易精神状态检查和蒙特利尔认知评估评分呈正相关,IPL 厚度与内侧颞叶萎缩评分呈负相关,GCL 厚度与 CSF Aβ/Aβ 呈正相关,与 p-tau 水平呈负相关。基于两组间显著降低的 OCT 变量,XGBoost 算法对 AD 具有最佳的诊断性能,其准确度、曲线下面积、f1 评分和召回率等四个参考值范围为 0.69 至 0.74。此外,与所有 ML 模型中的其他纳入变量相比,黄斑视网膜厚度在 AD 诊断中具有绝对优势。
我们确定了 AD 患者的视网膜改变,并发现黄斑厚度和体积与 AD 严重程度和生物标志物相关。此外,我们证实 OCT 结合 ML 可作为 AD 的潜在诊断工具。